Iba T, Fukunaga T, Sugiyama K, Kawabata M, Fukunaga M, Kidokoro A, Yagi Y
Dept. of Surgery, Urayasu Hospital, Juntendo University School of Medicine, Japan.
Gan To Kagaku Ryoho. 1992 Jun;19(6):897-900.
A case of unresectable gall bladder cancer due to multiple metastasis was dealt with EAP (VP-16, ADM, CDDP) treatment. The case was a 49-year-old male who was admitted to the hospital with a 3 cm sized umbilical tumor. After 2 cycles of the treatment, the tumor size significantly decreased and the symptoms diminished. In parallel, the symptoms from bone metastasis and dissemination also disappeared. As for tumor markers, CA 19-9 indicated 5151 U/ml, fell down to the normal range after the treatment. In this case, the efficacy of EAP treatment to the primary gall bladder carcinoma was undetectable, because of the difficulty of elucidation of the primary site by diagnostic images. However, all data suggested that EAP treatment was effective to the advanced unresectable gallbladder cancer, at least to its metastatic sites.
一例因多发转移而无法切除的胆囊癌患者接受了EAP(依托泊苷、多柔比星、顺铂)治疗。该病例为一名49岁男性,因脐部出现一个3厘米大小的肿瘤而入院。经过2个周期的治疗,肿瘤大小显著减小,症状减轻。同时,骨转移和扩散引起的症状也消失了。至于肿瘤标志物,CA 19-9显示为5151 U/ml,治疗后降至正常范围。在该病例中,由于诊断影像难以明确原发部位,无法检测到EAP治疗对原发性胆囊癌的疗效。然而,所有数据表明,EAP治疗对晚期无法切除的胆囊癌有效,至少对其转移部位有效。